Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome ...

The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent by ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...

The WHO Foundation proudly announces a five-year partnership with the number one cosmetics brand in the world, Maybelline New ...

Global Pleural Diseases Therapeutics MarketThe global market for pleural diseases therapeutics is projected to experience ...

One of the primary factors fueling the growth of the DOACs market is the rapid uptake and expected utilization within the ...

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

The medicine, which Novo sells as Rybelsus, cut the risk of cardiovascular complications by 14% when added to standard ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

Madrigal faces financial challenges and competition for Rezdiffra. Read more to understand why MDGL stock is downgraded from ...